Pharmacognosy

From DrugPedia: A Wikipedia for Drug discovery

(Difference between revisions)
Jump to: navigation, search
(New page: The word Pharmacognosy is derived from two Greek words, ‘Pharmakon’ meaning ‘drug’ and ‘gnosis’ meaning ‘knowledge’. Therefore, Pharmacognosy literally means knowledge of d...)
Current revision (04:23, 1 September 2008) (edit) (undo)
 
(2 intermediate revisions not shown.)
Line 11: Line 11:
* efficacy (therapeutic indications, clinical studies, pharmacological investigations)
* efficacy (therapeutic indications, clinical studies, pharmacological investigations)
* safety (adverse reactions, drug interactions, contraindications, precautions)
* safety (adverse reactions, drug interactions, contraindications, precautions)
-
Pharmacognosy is interdisciplinary, drawing on a broad spectrum of biological and socio-scientific subjects, including [[botany]], [[ethnobotany]], [[medical anthropology]], [[marine biology]], [[microbiology]], [[herbal medicine]], [[chemistry]] ([[phytochemistry]]), [[pharmacology]], [[pharmaceutics]], clinical [[pharmacy]] and [[pharmacy practice]]. The contemporary study of pharmacognosy can be divided into the fields of
+
Pharmacognosy is interdisciplinary, drawing on a broad spectrum of biological and socio-scientific subjects, including botany, ethnobotany, medical anthropology, marine biology, [[microbiology]], [[herbal medicine]], chemistry phytochemistry, [[pharmacology]], [[pharmaceutics]], clinical pharmacy and pharmacy practice. The contemporary study of pharmacognosy can be divided into the fields of
-
*medical [[ethnobotany]]: the study of the traditional use of plants for medicinal purposes;
+
*medical ethnobotany: the study of the traditional use of plants for medicinal purposes;
-
*[[ethnopharmacology]]: the study of the pharmacological qualities of traditional medicinal substances;
+
*ethnopharmacology: the study of the pharmacological qualities of traditional medicinal substances;
-
*the study of [[phytotherapy]] (the medicinal use of plant extracts); and
+
*the study of phytotherapy (the medicinal use of plant extracts); and
-
*[[phytochemistry]], the study of chemicals derived from plants (including the identification of new drug candidates derived from plant sources).
+
*phytochemistry, the study of chemicals derived from plants (including the identification of new drug candidates derived from plant sources).
 +
 
 +
==Ethnopharmacology==
 +
When studying the effectiveness of herbal medicines and other nature-derived remedies, the information of the traditional uses of certain extracts of even extract combinations plays a key role. The lack of studies proving the use of herbs in traditional care is especially an issue in the United States where the use of herbal medicine has fallen out of use since the Second World War and was considered suspect since the Flexner Report of 1910 led to the closing of the eclectic medical schools where botanical medicine was exclusively practiced. This is further complicated by most herbal studies in the latter part of the 20th Century having been published in languages other than English language|English such as German language|German, Dutch language|Dutch, Chinese language|Chinese, Japanese language|Japanese, Korean language|Korean and Persian language|Persian. As it may be more difficult to review foreign language publications, many of these publications have undergone been incorporated into the US Food and Drug Administration's "[[FDA]]" determinations of drug safety. In 1994 the US Congress passed the Dietary Supplement Health and Education Act (DSHEA), regulating labeling and sales of herbs and other supplements. Most of the 2000 US companies making herbal or natural products choose to market their products as food supplements that do not require substantial testing.
 +
 
 +
==Issues in Phytotherapy==
 +
The part of pharmacognosy focusing on use of crude extracts or semi-pure mixtures originating from nature, namely phytotherapy, is probably the best known and also the most debated area in pharmacognosy. Although phytotherapy is sometimes connected to alternative medicine, when critically conducted, it may be considered the scientific study on the effects and clinical use of herbal medicines. 
 +
 
 +
===Constituents and Drug Synergyism===
 +
One characteristic of crude drug material is that constituents may have an opposite, moderating or enhancing effect. Hence, the final effect of any crude drug material will be a product of the interactions between the constituents and the effect of each constituent on its own. To effectively study the existence and affect of such interactions, scientific studies must examine the affect that multiple constituents, given concurrently, have on the system. Herbalists assert that as phytopharmaceuticals rely upon synergy#drug_synergism|synergy for their activities, plants with high levels of active constituents like ginsenosides or hypericin may not correlate with the strength of the herbs. In phytopharmaceutical or [[herbal medicine]], the therapeutic effects of herbs cannot be determined unless its active ingredient or cofactors]are identified or the herb is adminsistered as a whole. One way manufacturers have attempted to indicate strength is to engage in standardization to a marker compound. Companies use different markers, or different levels of the same markers, or different methods of testing for marker compounds.
 +
 
 +
===Herb and Drug Interactions===
 +
The Sloan Kettering Memorial Cancer Center stated, in a review of a Juice product, which had been marketed as preventing cancer, that antioxidants could theoretically interfere with chemotherapy.
 +
 
 +
==Natural products chemistry==
 +
Most bioactive compounds of natural origin are secondary metabolites, i.e. species-specific chemical agents that can be grouped into various categories . A typical protocol to isolate a pure chemical agent from natural origin is bioassay-guided fractionation, meaning step-by-step separation of extracted components based on differences in their physicochemical properties, and assessing the biological activity, followed by next round of separation and assaying. Typically, such work is initiated after a given crude drug formulation (typically prepared by solvent extraction of the natural material) is deemed "active" in a particular ''in vitro'' assay. If the end-goal of the work at hand is to identify which one(s) of the scores or hundreds of compounds are responsible for the observed ''in vitro'' activity, the path to that end is fairly straightforward:
 +
1. fractionate the crude extract, e.g. by solvent partitioning or chromatography.
 +
2. test the fractions thereby generated with ''in vitro'' assay.
 +
3. repeat steps 1) and 2) until pure, active compounds are obtained. 
 +
4. determine structure(s) of active compound(s), typically by using spectroscopic methods.
 +
It should be stressed here that '''''in vitro'' activity does not necessarily translate to activity in humans''' or other living systems.
 +
The most common means for fractionation are solvent-solvent partitioning and chromatographic techniques such as high-performance liquid chromatography (HPLC), medium-pressure liquid chromatography, "flash" chromatography, open-column chromatography, vacuum-liquid chromatography (VLC), thin-layer chromatography (TLC), with each technique being most appropriate for a given amount of starting material. Countercurrent chromatography (CCC) is particularly well-suited for bioassay-guided fractionation because, as an all-liquid separation technique, concern about irreversible loss or denaturation of active sample components is minimized. After isolation of a pure substance, the task of elucidating its chemical structure can be addressed. For this purpose, the most powerful methodologies available are nuclear magnetic resonance spectroscopy (NMR) and mass spectroscopy (MS) . In the case of drug discovery efforts, structure elucidation of all components that are active ''in vitro'' is typically the end goal. In the case of phytotherapy research, the investigator may use ''in vitro'' BAGF as a tool to identify pharmacologically interesting or important components of the crude drug. The work does not stop after structural identification of ''in vitro'' actives, however.  The task of "dissecting and reassembling" the crude drug one active component at a time, in order to achieve a mechanistic understanding of how it works in phytotherapy, is quite daunting. This is because it is simply too difficult, from cost, time, regulatory, and even scientific perspectives, to study experimental fractions of the crude drug in humans.  ''In vitro'' assays are therefore used to identify chemical components of the crude drug that may rationally be expected to have a given pharmacological effect in humans, and to provide a rational basis for standardization of a crude drug formulation to be tested in [and sold/marketed to] humans.
 +
 
 +
==Sustainable Sources of Plant and Animal Drugs==
 +
 
 +
As species face loss of habitat or overharvesting, there have been new issues to deal with in sourcing crude drugs. These include changes to the herb from farming practices, substitution of species or other plants altogether, adulteration and cross-pollination issues. For instance, ginseng which is field farmed may have significant problems with fungus, making contamination with fungicides an issue. This may be remedied with woods grown programs, but they are insufficient to produce enough ginseng to meet demand. The wildcrafted echinacea, black cohosh and American ginseng often rely upon old growth root, often in excess of 50 years of age and it is not clear that younger stock will have the same pharmaceutical effect.< Black cohosh may be adulterated with the related Chinese actea species, which is not the same. Ginseng may be replaced by ginseniodes from Jiaogulan which has been stated to have a different effect than the full panax root.
 +
The problem may be exacerbated by the growth of pills and capsules as the preferred method of ingesting medication as they are cheaper and more available than traditional, individually tailored prescriptions of raw medicinals but the contents are harder to track. Seahorses are a case in point: Seahorses once had to be of a certain size and quality before they were accepted by practitioners and consumers. But declining availability of the preferred large, pale and smooth seahorses has been offset by the shift towards prepackaged medicines, which make it possible for TCM merchants to sell previously unused juvenile, spiny and dark-coloured animals. Today almost a third of the seahorses sold in China are prepackaged.
 +
 
 +
*One solution is to farm medicinal animals and plants. Chinese officials have promoted this as a way of guaranteeing supplies as well as protecting endangered species. And there have been some successes—notably with plant species, such as American ginseng—which is used as a general tonic and for chronic coughs. Red deer, too, have for centuries been farmed for their antlers, which are used to treat impotence and general fatigue. But growing your own is not a universal panacea. Some plants grow so slowly that cultivation in not economically viable. Animals such as musk deer may be difficult to farm, and so generate little profit. Seahorses are difficult to feed and plagued by disease in captivity. Other species cannot be cultivated at all. Even when it works, farming usually fails to match the scale of demand. Overall, cultivated TCM plants in China supply less than 20 per cent of the required 1.6 million tonnes per annum. Similarly, China's demand for animal products such as musk and pangolin scales far exceeds supply from captive-bred sources.
 +
 
 +
*Farming alone can never resolve conservation concerns, as government authorities and those who use Chinese medicine realise. For a start, consumers often prefer ingredients taken from the wild, believing them to be more potent. This is reflected in the price, with wild oriental ginseng fetching up to 32 times as much as cultivated plants. Then there are welfare concerns. Bear farming in China is particularly controversial. Around 7600 captive bears have their bile "milked" through tubes inserted into their gall bladders. The World Society for the Protection of Animals states that bear farming is surrounded by "appalling levels of cruelty and neglect"  The Trade in Bear Bile: Courtesy of World Society for the Protection of Animals. Chinese officials state that 10 000 wild bears would need to be killed each year to produce as much bile, making bear farming the more desirable option. The World society for the Protection of Animals, however, states that "it is commonly believed in China that the bile from a wild bear is the most potent, and so farming bears for their bile cannot replace the demand for the product extracted from wild animals".
 +
 
 +
*One alternative to farming involves replacing medical ingredients from threatened species with manufactured chemical compounds. In general, this sort of substitution is difficult to achieve because the active ingredient is often not known. In addition, most TCM users believe that TCM compounds may act synergistically so several ingredients may interact to give the required effect. Thus TCM users often people prefer the wild source. Tauro ursodeoxycholic acid, the active ingredient of bear bile, can be synthesised and is used by some Western doctors to treat gallstones, but many TCM consumers reject it as being inferior to the natural substance from wild animals.
 +
 
 +
==External links==
 +
* [http://www.phcog.org American Society of Pharmacognosy]
 +
* [http://www.ga-online.org GA/Society for Medicinal Plant Research]
 +
* [http://www.escop.com/ ESCOP-European Scientific Cooperative on Phytotherapy]
 +
* [http://www.ethnopharmacology.org International Society for Ethnopharmacology]
 +
* [http://www.herbalgram.org/ American Botanical Council]
 +
* [http://www.ethnobiomed.com/ Journal of Ethnobiology and Ethnomedicine]
 +
* [http://www.pharmacy.ac.uk/pharmacognosy.html Centre for Pharmacognosy and Phytotherapy, School of Pharmacy, University of London]

Current revision

The word Pharmacognosy is derived from two Greek words, ‘Pharmakon’ meaning ‘drug’ and ‘gnosis’ meaning ‘knowledge’. Therefore, Pharmacognosy literally means knowledge of drugs. Pharmacognosy is one of the important branches of pharmacy. It deals with “ the study of structural, physical, chemical and sensory characters of crude drugs of animal, vegetable and mineral origin and includes their history, cultivation, collection, storage and use. Pharmacognosy is nothing but medicinal botany.

Though the term Pharmacognosy is a modern one, the knowledge of medicinal plants and their uses are as old as humankind is. It has developed from ancient civilizations, where plants or plants parts have been used to cure human diseases / disorders. The healing power of certain herbs and plant parts such as leaves, barks, roots etc. were undoubtedly discovered by accident, but once discovered, knowledge of drugs was passed on from generation to generation.

Contents

[edit] Introduction

Pharmacology is the study of the biological effects that the chemicals in medicinal plants have on cell cultures, animals and humans. The renaissance of herbal medicine in this country creates a demand for studies in the field of pharmacognosy. From a practical perspective this includes:

  • quality control (identity, purity, consistency)
  • efficacy (therapeutic indications, clinical studies, pharmacological investigations)
  • safety (adverse reactions, drug interactions, contraindications, precautions)

Pharmacognosy is interdisciplinary, drawing on a broad spectrum of biological and socio-scientific subjects, including botany, ethnobotany, medical anthropology, marine biology, microbiology, herbal medicine, chemistry phytochemistry, pharmacology, pharmaceutics, clinical pharmacy and pharmacy practice. The contemporary study of pharmacognosy can be divided into the fields of

  • medical ethnobotany: the study of the traditional use of plants for medicinal purposes;
  • ethnopharmacology: the study of the pharmacological qualities of traditional medicinal substances;
  • the study of phytotherapy (the medicinal use of plant extracts); and
  • phytochemistry, the study of chemicals derived from plants (including the identification of new drug candidates derived from plant sources).

[edit] Ethnopharmacology

When studying the effectiveness of herbal medicines and other nature-derived remedies, the information of the traditional uses of certain extracts of even extract combinations plays a key role. The lack of studies proving the use of herbs in traditional care is especially an issue in the United States where the use of herbal medicine has fallen out of use since the Second World War and was considered suspect since the Flexner Report of 1910 led to the closing of the eclectic medical schools where botanical medicine was exclusively practiced. This is further complicated by most herbal studies in the latter part of the 20th Century having been published in languages other than English language|English such as German language|German, Dutch language|Dutch, Chinese language|Chinese, Japanese language|Japanese, Korean language|Korean and Persian language|Persian. As it may be more difficult to review foreign language publications, many of these publications have undergone been incorporated into the US Food and Drug Administration's "FDA" determinations of drug safety. In 1994 the US Congress passed the Dietary Supplement Health and Education Act (DSHEA), regulating labeling and sales of herbs and other supplements. Most of the 2000 US companies making herbal or natural products choose to market their products as food supplements that do not require substantial testing.

[edit] Issues in Phytotherapy

The part of pharmacognosy focusing on use of crude extracts or semi-pure mixtures originating from nature, namely phytotherapy, is probably the best known and also the most debated area in pharmacognosy. Although phytotherapy is sometimes connected to alternative medicine, when critically conducted, it may be considered the scientific study on the effects and clinical use of herbal medicines.

[edit] Constituents and Drug Synergyism

One characteristic of crude drug material is that constituents may have an opposite, moderating or enhancing effect. Hence, the final effect of any crude drug material will be a product of the interactions between the constituents and the effect of each constituent on its own. To effectively study the existence and affect of such interactions, scientific studies must examine the affect that multiple constituents, given concurrently, have on the system. Herbalists assert that as phytopharmaceuticals rely upon synergy#drug_synergism|synergy for their activities, plants with high levels of active constituents like ginsenosides or hypericin may not correlate with the strength of the herbs. In phytopharmaceutical or herbal medicine, the therapeutic effects of herbs cannot be determined unless its active ingredient or cofactors]are identified or the herb is adminsistered as a whole. One way manufacturers have attempted to indicate strength is to engage in standardization to a marker compound. Companies use different markers, or different levels of the same markers, or different methods of testing for marker compounds.

[edit] Herb and Drug Interactions

The Sloan Kettering Memorial Cancer Center stated, in a review of a Juice product, which had been marketed as preventing cancer, that antioxidants could theoretically interfere with chemotherapy.

[edit] Natural products chemistry

Most bioactive compounds of natural origin are secondary metabolites, i.e. species-specific chemical agents that can be grouped into various categories . A typical protocol to isolate a pure chemical agent from natural origin is bioassay-guided fractionation, meaning step-by-step separation of extracted components based on differences in their physicochemical properties, and assessing the biological activity, followed by next round of separation and assaying. Typically, such work is initiated after a given crude drug formulation (typically prepared by solvent extraction of the natural material) is deemed "active" in a particular in vitro assay. If the end-goal of the work at hand is to identify which one(s) of the scores or hundreds of compounds are responsible for the observed in vitro activity, the path to that end is fairly straightforward: 1. fractionate the crude extract, e.g. by solvent partitioning or chromatography. 2. test the fractions thereby generated with in vitro assay. 3. repeat steps 1) and 2) until pure, active compounds are obtained. 4. determine structure(s) of active compound(s), typically by using spectroscopic methods. It should be stressed here that in vitro activity does not necessarily translate to activity in humans or other living systems. The most common means for fractionation are solvent-solvent partitioning and chromatographic techniques such as high-performance liquid chromatography (HPLC), medium-pressure liquid chromatography, "flash" chromatography, open-column chromatography, vacuum-liquid chromatography (VLC), thin-layer chromatography (TLC), with each technique being most appropriate for a given amount of starting material. Countercurrent chromatography (CCC) is particularly well-suited for bioassay-guided fractionation because, as an all-liquid separation technique, concern about irreversible loss or denaturation of active sample components is minimized. After isolation of a pure substance, the task of elucidating its chemical structure can be addressed. For this purpose, the most powerful methodologies available are nuclear magnetic resonance spectroscopy (NMR) and mass spectroscopy (MS) . In the case of drug discovery efforts, structure elucidation of all components that are active in vitro is typically the end goal. In the case of phytotherapy research, the investigator may use in vitro BAGF as a tool to identify pharmacologically interesting or important components of the crude drug. The work does not stop after structural identification of in vitro actives, however. The task of "dissecting and reassembling" the crude drug one active component at a time, in order to achieve a mechanistic understanding of how it works in phytotherapy, is quite daunting. This is because it is simply too difficult, from cost, time, regulatory, and even scientific perspectives, to study experimental fractions of the crude drug in humans. In vitro assays are therefore used to identify chemical components of the crude drug that may rationally be expected to have a given pharmacological effect in humans, and to provide a rational basis for standardization of a crude drug formulation to be tested in [and sold/marketed to] humans.

[edit] Sustainable Sources of Plant and Animal Drugs

As species face loss of habitat or overharvesting, there have been new issues to deal with in sourcing crude drugs. These include changes to the herb from farming practices, substitution of species or other plants altogether, adulteration and cross-pollination issues. For instance, ginseng which is field farmed may have significant problems with fungus, making contamination with fungicides an issue. This may be remedied with woods grown programs, but they are insufficient to produce enough ginseng to meet demand. The wildcrafted echinacea, black cohosh and American ginseng often rely upon old growth root, often in excess of 50 years of age and it is not clear that younger stock will have the same pharmaceutical effect.< Black cohosh may be adulterated with the related Chinese actea species, which is not the same. Ginseng may be replaced by ginseniodes from Jiaogulan which has been stated to have a different effect than the full panax root. The problem may be exacerbated by the growth of pills and capsules as the preferred method of ingesting medication as they are cheaper and more available than traditional, individually tailored prescriptions of raw medicinals but the contents are harder to track. Seahorses are a case in point: Seahorses once had to be of a certain size and quality before they were accepted by practitioners and consumers. But declining availability of the preferred large, pale and smooth seahorses has been offset by the shift towards prepackaged medicines, which make it possible for TCM merchants to sell previously unused juvenile, spiny and dark-coloured animals. Today almost a third of the seahorses sold in China are prepackaged.

  • One solution is to farm medicinal animals and plants. Chinese officials have promoted this as a way of guaranteeing supplies as well as protecting endangered species. And there have been some successes—notably with plant species, such as American ginseng—which is used as a general tonic and for chronic coughs. Red deer, too, have for centuries been farmed for their antlers, which are used to treat impotence and general fatigue. But growing your own is not a universal panacea. Some plants grow so slowly that cultivation in not economically viable. Animals such as musk deer may be difficult to farm, and so generate little profit. Seahorses are difficult to feed and plagued by disease in captivity. Other species cannot be cultivated at all. Even when it works, farming usually fails to match the scale of demand. Overall, cultivated TCM plants in China supply less than 20 per cent of the required 1.6 million tonnes per annum. Similarly, China's demand for animal products such as musk and pangolin scales far exceeds supply from captive-bred sources.
  • Farming alone can never resolve conservation concerns, as government authorities and those who use Chinese medicine realise. For a start, consumers often prefer ingredients taken from the wild, believing them to be more potent. This is reflected in the price, with wild oriental ginseng fetching up to 32 times as much as cultivated plants. Then there are welfare concerns. Bear farming in China is particularly controversial. Around 7600 captive bears have their bile "milked" through tubes inserted into their gall bladders. The World Society for the Protection of Animals states that bear farming is surrounded by "appalling levels of cruelty and neglect" The Trade in Bear Bile: Courtesy of World Society for the Protection of Animals. Chinese officials state that 10 000 wild bears would need to be killed each year to produce as much bile, making bear farming the more desirable option. The World society for the Protection of Animals, however, states that "it is commonly believed in China that the bile from a wild bear is the most potent, and so farming bears for their bile cannot replace the demand for the product extracted from wild animals".
  • One alternative to farming involves replacing medical ingredients from threatened species with manufactured chemical compounds. In general, this sort of substitution is difficult to achieve because the active ingredient is often not known. In addition, most TCM users believe that TCM compounds may act synergistically so several ingredients may interact to give the required effect. Thus TCM users often people prefer the wild source. Tauro ursodeoxycholic acid, the active ingredient of bear bile, can be synthesised and is used by some Western doctors to treat gallstones, but many TCM consumers reject it as being inferior to the natural substance from wild animals.

[edit] External links